Harvard Reproductive Endocrine Sciences Center and the Reproductive Endocrine Unit of the Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
J Clin Endocrinol Metab. 2010 Jun;95(6):3019-27. doi: 10.1210/jc.2009-2582. Epub 2010 Apr 9.
Idiopathic hypogonadotropic hypogonadism (IHH) with normal smell (normosmic IHH) or anosmia (Kallmann syndrome) is associated with defects in the production or action of GnRH. Accordingly, most IHH patients respond to physiological pulsatile GnRH replacement by normalizing serum LH, FSH, and testosterone (T) levels and achieving gametogenesis; some patients, however, show atypical responses. Interestingly, several IHH-associated genes are expressed in multiple compartments of the hypothalamic-pituitary-gonadal axis.
The aim of the study was to investigate whether the clinical, biochemical, or genetic characteristics of IHH men with atypical responses to GnRH indicate alternative or additional defects in the hypothalamic-pituitary-gonadal axis.
We studied 90 IHH men undergoing long-term pulsatile GnRH treatment over 30 yr.
We conducted a retrospective study of response to GnRH at a Clinical Research Center.
Physiological regimens of pulsatile s.c. GnRH were administered for at least 12 months. Dose-response studies using i.v. GnRH pulses assessed the pituitary LH response.
We measured serum T, LH, FSH, and inhibin B levels, sperm in ejaculate, and determined the sequence of IHH-associated genes.
Twenty-six percent of subjects displayed atypical responses to GnRH: 1) 10 remained hypogonadotropic and hypogonadal, demonstrating pituitary and testicular defects; 2) eight achieved spermatogenesis and normal T but only with hypergonadotropism, indicating impaired testicular responsiveness to gonadotropins; and 3) five remained azoospermic despite achieving adult testicular volumes and normal hormonal profiles, suggesting primary defects in spermatogenesis. Mutations were identified only in KAL1 across groups.
In addition to hypothalamic GnRH deficiency, IHH men can have primary pituitary and/or testicular defects, which are unmasked by GnRH replacement.
特发性低促性腺激素性性腺功能减退症(IHH)伴正常嗅觉(正常嗅觉 IHH)或嗅觉缺失(卡尔曼综合征)与 GnRH 的产生或作用缺陷有关。因此,大多数 IHH 患者通过使血清 LH、FSH 和睾酮(T)水平正常化并实现配子发生对生理脉冲 GnRH 替代作出反应;然而,一些患者表现出非典型反应。有趣的是,一些与 IHH 相关的基因在下丘脑-垂体-性腺轴的多个隔室中表达。
本研究旨在探讨对 GnRH 呈非典型反应的 IHH 男性的临床、生化或遗传特征是否表明下丘脑-垂体-性腺轴存在其他或额外的缺陷。
我们研究了 90 名接受长期脉冲 GnRH 治疗超过 30 年的 IHH 男性。
我们在临床研究中心进行了 GnRH 反应的回顾性研究。
至少 12 个月给予生理脉冲皮下 GnRH 治疗方案。使用静脉内 GnRH 脉冲进行剂量反应研究评估垂体 LH 反应。
我们测量了血清 T、LH、FSH 和抑制素 B 水平、精液中的精子,并确定了 IHH 相关基因的序列。
26%的受试者对 GnRH 呈非典型反应:1)10 例仍为促性腺激素低下和性腺功能减退,表现为垂体和睾丸缺陷;2)8 例实现了精子发生和正常 T,但仅表现为高促性腺激素血症,表明睾丸对促性腺激素的反应受损;3)5 例尽管达到了成人睾丸体积和正常激素谱,但仍无精子,提示精子发生的原发性缺陷。仅在各组中发现了 KAL1 的突变。
除了下丘脑 GnRH 缺乏之外,IHH 男性还可能存在原发性垂体和/或睾丸缺陷,这些缺陷在 GnRH 替代治疗时会显现出来。